Jan Basile to Diabetes Mellitus, Type 2
This is a "connection" page, showing publications Jan Basile has written about Diabetes Mellitus, Type 2.
Connection Strength
2.209
-
How We Got Where We Are in Blood Pressure Targets. Curr Hypertens Rep. 2021 06 10; 23(6):33.
Score: 0.392
-
A Multifactorial Approach to Reduce Cardiovascular Disease in Type 2 Diabetes Mellitus: Now More Than Ever. Hosp Pract (1995). 2016; 44(1):9-20.
Score: 0.271
-
The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM). J Diabetes Complications. 2013 May-Jun; 27(3):280-6.
Score: 0.220
-
Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease. J Clin Hypertens (Greenwich). 2013 Jan; 15(1):2-4.
Score: 0.216
-
A new approach to glucose control in type 2 diabetes: the role of kidney sodium-glucose co-transporter 2 inhibition. Postgrad Med. 2011 Jul; 123(4):38-45.
Score: 0.197
-
Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):472-7.
Score: 0.184
-
Antihypertensive therapy, new-onset diabetes, and cardiovascular disease. Int J Clin Pract. 2009 Apr; 63(4):656-66.
Score: 0.167
-
Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2007 May; 9(5):396.
Score: 0.147
-
Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction. J Cardiometab Syndr. 2006; 1(5):358-61.
Score: 0.135
-
Orthostatic Hypotension in the ACCORD (Action to Control Cardiovascular Risk in Diabetes) Blood Pressure Trial: Prevalence, Incidence, and Prognostic Significance. Hypertension. 2016 10; 68(4):888-95.
Score: 0.070
-
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307.
Score: 0.068
-
Recent clinical trials. J Am Soc Hypertens. 2014 Oct; 8(10):770-4; quiz 775-6.
Score: 0.061
-
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29; 362(17):1575-85.
Score: 0.045
-
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
Score: 0.037